<DOC>
	<DOCNO>NCT00662116</DOCNO>
	<brief_summary>This study do evaluate safety effectiveness alagebrium subject diagnose diastolic heart failure . The primary assessment effectiveness assessment exercise tolerance .</brief_summary>
	<brief_title>Beginning Randomized Evaluation AGE Breaker Alagebrium Diastolic Heart Failure ( BREAK-DHF-I )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<criteria>diagnosis diabetes hypertension require therapy EF &gt; /= 45 % via echo within 1 year evidence diastolic heart failure via echo measurement E/E ' &gt; /= 12 determined echo within 1 year previous hospitalization heart failure previous BNP &gt; 100 pg/mL . Clinically significant valvular disease history stroke/TIA reversible ischemic neurological defect w/i 6 mths history acute MI within 6 month severe COPD active treat malignancy ( except basal cell carcinoma ) significant systemic illness would prohibit completion study compliance</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>diastolic heart failure</keyword>
</DOC>